Association between Alkaline Phosphatase and Anemia in Rural Japanese Men: The Nagasaki Islands study by Shimizu Yuji et al.
Acta Med. Nagasaki 58: 125−130−
1. Introduction
　Alkaline phosphatase (ALP) is an enzyme that catalyzes 
the hydrolysis of inorganic pyrophosphate.1 ALP is expressed 
in a variety of tissues, but its concentrations are notably high 
in bone, liver, and kidney.1 Previous studies reported that os-
teoblastic cells regulate the hematopoietic stem cell niche 
and are also important for production of blood corpuscles 
including red blood cells.2,3 Because activity of osteoblasts 
can be evaluated by bone-type ALP expression,1,4 lower ALP 
might be associated with anemia. Furthermore, under ane-
mic conditions, activity of osteoblasts might increase to 
compensate for hemoglobin insufficiency.5 These findings 
led us to speculate that not only reduced, but also elevated 
ALP levels may be associated with anemia.  
　However, women might not be suitable subjects for such 
an investigation not only because ALP is confounded by 
menopausal status,4,6 but also because hemoglobin levels are 
MS#AMN 07146
Association between Alkaline Phosphatase and Anemia in Rural Japanese 
Men: The Nagasaki Islands study
Yuji Shimizu,1,2 Mio Nakazato,2 Takaharu Sekita,2 Koichiro kadota,1 Shimpei Sato,1  Kazuhiko arima,3 
Noboru takamura,4 Kiyoshi aoyagi,3 Yosuke kuSaNo,5 Takahiro maeda1,2
1 Department of Community Medicine, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan
2 Department of Island and Community Medicine, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan
3 Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
4 Department of Global Health, Medicine and Welfare, Nagasaki University Graduate School of Biomedical Sciences Atomic Bomb Disease Institute, 
Nagasaki University, Nagasaki, Japan
5 Department of Internal Medicine, Nagasaki National Hospital, Nagasaki Japan
　Although bone metabolism is reportedly associated with production and maturation of blood corpuscles, and serum alkaline 
phosphatase (ALP) levels have been associated with bone metabolism, no published study has investigated the association 
between ALP and anemia. Furthermore, although ALP is known as an enzyme affected by alcohol consumption, there are no 
reports in the literature on associations between ALP and the risk of anemia in relation to drinking status. We conducted a 
cross-sectional study of 907 men aged 30-89 years undergoing a general health check-up to investigate the associations 
between ALP and anemia in relation to drinking status. Of the 907 participants, 120 men were diagnosed with anemia. The 
association between ALP and anemia was J-shaped. With the second quartile of ALP (194-228 IU/L) (Q2) as the reference 
group, the multivariable adjusted OR and 95%CI for anemia were 1.91 (95%CI: 0.96-3.82) for <194 IU/L (Q1), 1.84 (95%CI: 
0.93-3.62) for 229-277 IU/L (Q3) and 2.83 (95%CI:1.49-5.37) for >277 IU/L (Q4). When the analysis was limited to non-drink-
ers, the associations became stronger with corresponding values of 3.34 (95%CI: 1.28-8.74), 3.18 (95%CI: 1.28-7.88) and 
3.22 (95%CI:1.37-7.59). Not only lower but also higher levels of serum ALP are associated with anemia for men, especially 
non-drinkers. For analyses of associations between ALP and anemia, alcohol consumption should thus be considered a po-
tential confounder.
ACTA MEDICA NAGASAKIENSIA 58: 125−130, 2014
Key words: ALP, drinking status, Anemia, cross-sectional study, Men
　 　
Address correspondence: Department of Community Medicine, Nagasaki University Graduate School of Biomedical Science, Nagasaki, 
Japan
Received December 9, 2013; Accepted January 31, 2014
126 Yuji Shimizu et al.: Alkaline Phosphatase and Anemia
confounded by menstruation.  
　On the other hand, serum ALP levels are influenced by 
alcohol consumption,7,8 which has been found to be posi-
tively associated with hemoglobin levels.9 Since the preva-
lence of drinkers is high among Japanese men,10 a study to 
investigate the association between serum ALP and anemia 
among Japanese men should also take drinking status into 
account.
　We therefore limited our investigation to community-
dwelling Japanese men aged 30-89 who participated in a 
general health check-up between 2005 and 2010. 
2. Material and Methods 
2.1 Participants
    This study was approved by the Ethics Committee for Hu-
man Use of Nagasaki University (project registration num-
ber: 0501120073).
　The source population included 1,355 residents, 30 to 89 
years old, of the western rural community of the Goto Is-
lands, who participated in this study between 2005 and 2010. 
Data for blood pressure were missing for 3 men, for drinking 
status for 23 men, and for serum for 422 men so that a total 
of 448 subjects were excluded from this study. The remain-
ing 907 men with a mean age of 65.1 years (±10.5 standard 
deviation (SD); range 30-89) were enrolled in this study. 
2.2 Data Collection and Laboratory Measurements 
　Trained interviewers obtained information on smoking 
status, drinking status and medical history, as well as on the 
use of antihypertensive agents and medication for diabetes 
mellitus. Body weight and height were measured with an 
automatic body composition analyzer (BF-220; Tanita, To-
kyo, Japan) when blood samples were obtained. Systolic and 
diastolic blood pressures were recorded at rest.
　Fasting blood samples were collected in an EDTA-2K 
tube and a siliconized tube. Samples from the EDTA-2K 
tube were used for measuring hemoglobin with the sodium 
lauryl surfate (SLS)-hemoglobin method. Serum was sepa-
rated and stored at −20°C until assay. Following collection 
of blood samples after overnight fasting, serum and plasma 
were separated and stored at −20°C and −80°C, respec-
tively, until assay. Serum concentrations of triglyceride 
(TG), hemoglobin A1c (HbA1c), γ-glutamyltranspeptidase 
(GTP), alkaline phosphatase (ALP) and serum creatinine 
were measured with standard laboratory procedures.
　The glomerular filtration rate (GFR) was estimated by 
means of an established method with three variations recent-
ly proposed by a working group of the Japanese Chronic 
Kidney Disease Initiative.11 According to this adapted version, 
the formula for determining GFR was: GFR(mL/min/1.73 
m2) = 194 × (serum creatinine (enzyme method))-1.094× 
(age)-0.287× (0.739 for women). HbA1c was calculated with 
the following equation based on standardization by the Na-
tional Glycohemoglobin Standardization Program (NGSP) 
and recently proposed by a working group of the Japanese 
Diabetes Society (JDS): HbA1c(NGSP) = HbA1c(JDS) + 
0.4%.12 Diabetes was defined as HbA1c (NGSP) ≥ 6.5%, and/
or initiation of glucose-lowering medication or insulin ther-
apy.13 Anemia for men was defined in accordance with the 
recommendation by the World Health Organization (WHO) 
Study Group: hemoglobin <13 g/dL.14
2.3 Statistical Analysis
　Differences in age-adjusted mean values or prevalence of 
potential confounding factors were calculated by ALP 
quartile using covariance or general linear models, and lo-
gistic regression models were used for calculating odds ra-
tios (OR) and 95% confidence intervals (CI) to determine 
associations of anemia with ALP values. 
　Two different approaches were used to adjust for con-
founding factors. The first adjustment was only for age, and 
the second consisted of other possible confounding factors, 
that is, smoking status (never smoker, former smoker, cur-
rent smoker), alcohol consumption (non-drinker, current 
light to moderate drinker (1-6 times/week) and current heavy 
drinker (every day)), diabetes (no, yes), history of cardiovas-
cular disease (no, yes), history of liver disease (no, yes), thy-
roid disease (no, yes), TG (mg/dL), γ-GTP (IU/L) and GFR 
(mL/min/1.73m2). In addition, subjects were stratified by 
drinking status because alcohol consumption has been asso-
ciated with ALP levels,7, 8 and several studies reported that 
hemoglobin levels of drinkers were higher than those of 
non-drinkers.8,15
　All statistical analyses were performed with the SAS sys-
tem for Windows (version 9.3; SAS Inc., Cary, NC). All p-
values for statistical tests were two-tailed, and values of 
<0.05 were regarded as statistically significant.
3. Results
　Of the 907 men, 120 were diagnosed with anemia. The 
prevalence of non-drinkers was 49.1%.
　Table 1 shows age-adjusted baseline characteristics by 
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ALP level. Serum γ-GTP was positively associated, and cur-
rent drinker status inversely associated with ALP levels. No 
significant association was observed for hemoglobin. 
　Table 2 shows the odds ratios (OR) and 95% confidence 
intervals (CI) for anemia according to ALP levels. The as-
sociation between ALP levels and anemia was J-shaped. 
With second quartile (Q2) of ALP (194-228 IU/L) as the ref-
erence group, the multivariable adjusted OR and 95%CI for 
anemia were 1.91 (95%CI: 0.96-3.82) for <194 IU/L (Q1), 
1.84 (95%CI: 0.93-3.62) for 229-277 IU/L (Q3) and 2.83 
(95%CI:1.49-5.37) for >277 IU/L (Q4).
　We also investigated the influence of drinking status [non-
drinker, current light-to-moderate drinker (1-6 times/week), 
and current heavy-drinker (every day)] on ALP and hemo-
globin levels. The association for ALP was significantly in-
verse while that for hemoglobin was significantly positive. 
The age-adjusted mean values of ALP were 253 for non-
drinkers, 238 for current light-to-moderate drinkers, and 234 
for current heavy drinkers (P=0.006) and the corresponding 
values of hemoglobin were 14.2 g/dL, 14.4g/dL and 14.6g/
dL (P<0.001).
　Table 3 shows OR and 95% CI for anemia by ALP level in 
relation to drinking status. The J-shaped association between 
ALP levels and anemia was observed only for non-drinkers. 
With the second quartile (Q2) as the reference group, the 
multivariable adjusted OR and 95%CI for anemia were 3.34 
(95%CI: 1.28-8.74) for Q1, 3.18 (95%CI: 1.28-7.88) for Q3 
and 3.22 (95%CI:1.37-7.59) for Q4.
Table 1. Age-adjusted mean values and proportions in terms of  alkaline phosphatase (ALP) levels. 
Alkaline phosphatase (ALP) quartiles
p
Q1 (low) Q2 Q3 Q4 (high)
Median values of Serum alkaline phosphatase (ALP), IU/L
No. at risk
Age, year 
Systolic blood pressure, mmHg
Antihypertensive medication use, %
Body mass index, kg/m2
Current drinker, % 
Current smoker, %
Diabetes, %
History of cardiovascular disease, %
History of liver disease, % 
Thyroid disease, % 
Hemoglobin, g/dL
Serum triglycerides (TG), mg/dL
Serum γ-glutamyltranspeptidase (γ-GTP), IU/L
Serum creatinine, mg/dL



















































































Age: mean ± standard deviation. p: p factor. Serum alkaline phosphatase (ALP) levels for quartiles were <194IU/L, 194-228IU/L, 229-277IU/L, and >277IU/L.
Table 2. Odds ratios (OR) and 95% confidence intervals (CI) for anemia by ALP level quartile for all subjects
ALP quartiles 1 SD increments 
in ALPQ1 (low) Q2 Q3 Q4 (high) P for trend
No. at risk























Multivariable OR: adjusted further for age, systolic blood pressure, antihypertensive medication use, body mass index, smoking, alcohol intake, diabetes, 
thyroid disease, history of cardiovascular disease, history of liver disease, serum triglycerides, serum γ-glutamyltranspeptidase (γ-GTP) and glomerular filtra-
tion rate (GFR). Anemia : defined as hemoglobin <13.0g/dL. ALP levels for quartiles were <194IU/L, 194-228IU/L, 229-277IU/L, and >277IU/L. * : analyses 
were performed for ALP ≥ 194IU/L.
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4. Discussion
 
　Our findings demonstrate that the association between se-
rum ALP and anemia is J-shaped and that this association is 
confined to non-drinkers. For analyses of associations be-
tween ALP and anemia, alcohol consumption should thus be 
considered a potential confounder.
　A previous study using 69,864 ALP measurements report-
ed that 130 (0.19%) of them showed low ALP (<30U/L; ref-
erence range 30-115 U/L) and that 88 (67.7%) of these were 
comparable in age and sex and that only one case (1.2%) 
showed severe anemia.16 
　In our study, subjects whose ALP level was in the lowest 
quartile showed associations with anemia especially for non-
drinkers. We found further evidence that not only lower but 
also higher levels of ALP were associated with anemia, again 
especially for non-drinkers.   
　Side population hematopoietic stem cells in bone marrow 
decrease as individuals age,17,18 and this decline may be as-
sociated with an increase in the frequency of anemia and 
other hematopoietic disorders that are seen in the elderly.19 
Because osteoblasts, whose activity can be evaluated by 
bone-type ALP expression,4, 20 regulate the production of he-
matopoietic stem cells in bone marrow,2,3,20 serum ALP lev-
els may correlate with production of hematopoietic stem 
cells which also constitute an important determinant factor 
for hemoglobin level. Lower ALP levels may therefore be 
associated with anemia by signifying lower production of 
red blood cells. Lack of hyperfunction of bone marrow to 
compensate for anemia may also constitute an important 
mechanism for those associations. Under anemic conditions, 
activity of bone-marrow should increase to compensate for 
hemoglobin insufficiency.5 However, if the osteoblasts can-
not be activated by anemia, lower ALP may be associated 
with anemia.  
　A few previous reports have dealt with associations be-
tween ischemic stroke and anemia.21,22 And one of our stud-
ies, The Circulatory Risk in Community Study (CIRCS), 
found that not only higher but also lower ALP levels consti-
tute a risk for stroke might partly support the mechanism 
between lower ALP and anemia.7 
    On the other hand, the mechanisms that account for higher 
ALP also being associated with anemia have not been eluci-
dated. Since ALP may indicate productivity of hematopoi-
etic stem cells,2-4,20 higher ALP should be reflected in higher 
hemoglobin levels. In our present study, however, hemoglo-
bin was not associated with ALP levels, whereas anemia 
showed a significantly association. This may partly be ex-
plained by a different cause of anemia that is not only lower 
productivity of hemoglobin but also a drastic reduction of 
hemoglobin such as bleeding. To compensate for anemia 
caused by hemoglobin reduction, activity of hematopoietic 
stem cell production in bone marrow may increase, which 
would also results in ALP elevation. As for the reduced he-
moglobin productivity, the increased activity of hematopoi-
etic stem cell production in bone marrow is comparatively 
lower than that of caused by bleeding, which would result in 
low ALP levels (Fig 1). Those mechanisms may act as a con-
founding factor on the association between hemoglobin and 
ALP, so that not only compensated anemia with hemoglobin 
levels above 13g/mL but also not yet compensated anemia 
(Hb<13g/mL) may be an indication of higher ALP.
Table 3. Odds ratios (OR) and 95% confidence intervals (CI) for anemia by ALP level quartile in relation to drinking status
ALP quartiles 1 SD increments 
in ALPQ1 (low) Q2 Q3 Q4 (high) P for trend
Non-drinkers 
　No. at risk
















































Multivariable OR: adjusted further for age, systolic blood pressure, antihypertensive medication use, body mass index, smoking, alcohol intake, diabetes, thy-
roid disease, history of cardiovascular disease,  history of liver disease, serum triglycerides,  serum γ-glutamyltranspeptidase (γ-GTP) and glomerular filtration 
rate (GFR). Anemia : defined as hemoglobin <13.0g/dL. ALP levels for quartiles were <194IU/L, 194-228IU/L, 229-277IU/L, and >277IU/L. * : analyses were 
performed for ALP ≥ 194IU/L. 
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　This study has certain potential limitations, which warrant 
consideration. First, because the ALP isozyme was not mea-
sured,23 we could not assess which type of ALP was associ-
ated with the risk of anemia. Second, only limited data for 
thyroid disease were available, which may have confounded 
the associations between ALP and risk of anemia.9, 24 Further 
investigations using thyroid function data are therefore nec-
essary. Third, since no reticulocyte data were available, we 
could not evaluate any direct association between ALP and 
production of red blood cells. However, although we were 
able to establish a significant association between ALP and 
anemia, the age-adjusted mean values of hemoglobin showed 
no significant association with ALP. This could be partly ex-
plained by the effects of compensation for anemia. Further, 
although the association between ALP levels and risk of ane-
mia was shown to be independent of the traditional risk fac-
tors, we did not adjust for other potential confounders whose 
values were associated with ALP, such as calorie, protein, 
vitamin C, magnesium, and zinc deficiencies,16 nor the vol-
ume of alcohol consumption.     
　In conclusion, not only lower but also higher levels of se-
rum ALP are associated with anemia among men, especially 
for non-drinkers. For analyses of associations between ALP 
and anemia, alcohol consumption should thus be considered 
a potential confounder.
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Figure 1. Association between serum ALP and anemia. Hb:hemoglobin. Ability of compensation for anemia is a) (Hb↑) < b) (Hb↑↑).  
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